FibroBiologics/$FBLG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About FibroBiologics
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Ticker
$FBLG
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
13
ISIN
US31573L1052
Website
FibroBiologics Metrics
BasicAdvanced
$33M
-
-$0.22
-
-
Price and volume
Market cap
$33M
52-week high
$13.59
52-week low
$0.76
Average daily volume
215K
Financial strength
Current ratio
1.136
Quick ratio
1.056
Long term debt to equity
36.809
Total debt to equity
302.809
Interest coverage (TTM)
-926.13%
Management effectiveness
Return on assets (TTM)
-81.15%
Return on equity (TTM)
1,013.48%
Valuation
Price to book
13.81
Price to tangible book (TTM)
13.81
Price to free cash flow (TTM)
-2.246
Growth
Earnings per share change (TTM)
-71.24%
What the Analysts think about FibroBiologics
Analyst ratings (Buy, Hold, Sell) for FibroBiologics stock.
FibroBiologics Financial Performance
Revenues and expenses
FibroBiologics Earnings Performance
Company profitability
FibroBiologics News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for FibroBiologics stock?
FibroBiologics (FBLG) has a market cap of $33M as of May 23, 2025.
What is the P/E ratio for FibroBiologics stock?
The price to earnings (P/E) ratio for FibroBiologics (FBLG) stock is 0 as of May 23, 2025.
Does FibroBiologics stock pay dividends?
No, FibroBiologics (FBLG) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next FibroBiologics dividend payment date?
FibroBiologics (FBLG) stock does not pay dividends to its shareholders.
What is the beta indicator for FibroBiologics?
FibroBiologics (FBLG) does not currently have a Beta indicator.